Legal sources with official primary sources

Printed ·

Skip to main content
Skip to the answer

Source status and reading dates are reported separately. A reading date is not source verification.

Back to the act

EU regulatory register · EHDS

Article 31Authorised representatives

CELEX 32025R0327 · Read on 2026-08-31

Share this page

Short answer

1. Prior to making an EHR system available on the Union market, a manufacturer of an EHR system established outside of the Union shall, by written mandate, appoint an authorised representative which is established in the Union.

Verbatim from the article. Source: NovaCopilot · https://legal.exploreworldai.com/eu/rattsakter/helsodata-2025-327/artikel-31 · Short answer as data · Official text

Official text

Read from the EU Publications Office for this CELEX number. The wording stands as published; nothing here is rewritten or summarised.

1. Prior to making an EHR system available on the Union market, a manufacturer of an EHR system established outside of the Union shall, by written mandate, appoint an authorised representative which is established in the Union.

2. An authorised representative shall perform the tasks specified in the mandate agreed with the manufacturer. The mandate shall allow the authorised representative to do at least the following:

(a)

keep the EU declaration of conformity and the technical documentation referred to in Article 37 at the disposal of market surveillance authorities for the period referred to in Article 30(3);

(b)

further to a reasoned request from a market surveillance authority, provide authorities of the Member State concerned with a copy of the mandate and all the information and documentation necessary to demonstrate the conformity of an EHR system with the essential requirements laid down in Annex II as well as the common specifications referred to in Article 36;

(c)

inform without undue delay the manufacturer if the authorised representative has reason to believe that an EHR system is no longer in conformity with the essential requirements laid down in Annex II;

(d)

inform without undue delay the manufacturer about any complaint received from consumers or professional users;

(e)

cooperate with the market surveillance authorities, at their request, on any corrective action taken in relation to the EHR systems covered by their mandate;

(f)

terminate the mandate if the manufacturer does not comply with its obligations under this Regulation;

The article continues in the official text.

Open the article on EUR-Lex

Follow-up questions

The text is quoted from the official source and is not legal advice. A national court reads the language version that binds in its jurisdiction.

Verifiable trust signals

  • Source-linked answers and explicit evidence gaps
  • Obligations, controls, risks and consequences
  • Stable objects and verifiable checksums
  • Rule-based objects, optional source-linked reasoning
  • Model card, source status and audit

Model cardAudit